Merz to Absorb Costs of New Excise Tax on Certain Medical Devices

Merz Aesthetics announced that it does not intend to raise prices on medical devices, despite the new excise tax on the sale of certain medical devices of about 2.3 percent now going into effect, per the Patient Protection and Affordable Care Act. In a statement to clients and potential clients, Merz Aesthetics Vice President Jim Hartman noted that the company has opted to absorb the costs rather than raise prices on value partners and potential partners. “We continue to commit to being an excellent partner to your practice and helping your business thrive, through ongoing investment in programs that support you clinically, drive consumer demand and add value to your practice,” said Mr. Hartman. For more on Merz products, visit www.merzusa.com.